Consolidated Balance Sheets

             
In millions, except per share data
Years ended December 31
 
08
   
07
 
Assets
           
Current assets
           
Cash and cash equivalents
$
2,183.9
 
$
2,767.9
 
Investments available-for-sale, at fair value
 
2,652.8
   
3,726.3
 
Other invested assets, current
 
23.6
   
40.3
 
Premium and self-funded receivables
 
3,042.9
   
2,870.1
 
Other receivables
 
1,546.7
   
1,162.2
 
Income tax receivable
 
159.9
   
0.9
 
Securities lending collateral
 
529.0
   
854.1
 
Deferred tax assets, net
 
779.0
   
559.6
 
Other current assets
 
1,212.2
   
1,050.4
 
Total current assets
 
12,130.0
   
13,031.8
 
Long-term investments available-for-sale, at fair value
 
11,839.1
   
13,962.4
 
Other invested assets, long-term
 
703.2
   
752.9
 
Property and equipment, net
 
1,054.5
   
995.9
 
Goodwill
 
13,461.3
   
13,435.4
 
Other intangible assets
 
8,827.2
   
9,220.8
 
Other noncurrent assets
 
387.9
   
660.8
 
Total assets
$
48,403.2
 
$
52,060.0
 
Liabilities and shareholders’ equity
           
Liabilities
           
Current liabilities
           
Policy liabilities
           
Medical claims payable
$
6,184.7
 
$
5,788.0
 
Reserves for future policy benefits
 
64.5
   
63.7
 
Other policyholder liabilities
 
1,626.8
   
1,832.2
 
Total policy liabilities
 
7,876.0
   
7,683.9
 
Unearned income
 
1,087.7
   
1,114.6
 
Accounts payable and accrued expenses
 
2,856.5
   
2,909.6
 
Security trades pending payable
 
5.8
   
50.6
 
Securities lending payable
 
529.0
   
854.1
 
Short-term borrowings
 
98.0
   
 
Current portion of long-term debt
 
909.7
   
20.4
 
Other current liabilities
 
1,657.6
   
1,755.0
 
Total current liabilities
 
15,020.3
   
14,388.2
 
Long-term debt, less current portion
 
7,833.9
   
9,023.5
 
Reserves for future policy benefits, noncurrent
 
664.7
   
661.9
 
Deferred tax liability, net
 
2,098.9
   
3,004.4
 
Other noncurrent liabilities
 
1,353.7
   
1,991.6
 
Total liabilities
 
26,971.5
   
29,069.6
 
Shareholders’ equity
           
Common stock, par value $0.01, shares authorized 900,000,000; shares issued and outstanding: 503,230,575 and 556,212,039
 
5.0
   
5.6
 
Additional paid-in capital
 
16,843.0
   
18,441.1
 
Retained earnings
 
5,479.4
   
4,387.6
 
Accumulated other comprehensive (loss) income
 
(895.7
)
 
156.1
 
Total shareholders’ equity
 
21,431.7
   
22,990.4
 
Total liabilities and shareholders’ equity
$
48,403.2
 
$
52,060.0
 
The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in WellPoint’s 2008 Annual Report on Form 10-K.